uniQure N.V. (QURE) reached a significant support level, and could be a good pick for investors from

Top Wall Street analysts upgraded and downgraded several top companies, including Applied Materials,

HC Wainwright & Co. analyst Patrick R. Trucchio maintains uniQure (NASDAQ:QURE) with a Buy an

Capricor stock falls after the FDA schedules a July advisory committee meeting for Deramiocel, its D

LEXINGTON, Mass. and AMSTERDAM, June 25, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a lea

Mizuho analyst Uy Ear maintains uniQure (NASDAQ:QURE) with a Outperform and raises the price targ

Dow Jones index fell 200+ points on Monday. Backblaze Inc rose 30.4% after $335M data storage deal w

uniQure reported early seizure reductions in an AMT-260 epilepsy study, with no treatment-related se

FDA reverses its rejection of Regenxbio Navsunli, allowing the company to refile its gene therapy ap

Barclays analyst Eliana Merle upgrades uniQure (NASDAQ:QURE) from Equal-Weight to Overweight and

Goldman Sachs analyst Salveen Richter maintains uniQure (NASDAQ:QURE) with a Neutral and raises t

Leerink Partners analyst Joseph Schwartz maintains uniQure (NASDAQ:QURE) with a Outperform and ra

RBC Capital analyst Luca Issi maintains uniQure (NASDAQ:QURE) with a Outperform and raises the pr

U.S. stocks up, Dow Jones gains 0.39%. NASDAQ rose 0.09%, S&P 500 up 0.11%. Industrials shares j

uniQure stock surged after the FDA said three-year AMT-130 data could support accelerated approval f

U.S. stocks rose, with the Dow Jones gaining 200 points on Wed. Jabil Inc (JBL) shares surged 9.8% a

~ 3-year analysis from the Phase I/II study can serve as the primary basis of a Biologics License Ap

https://endpoints.news/acting-fda-commissioner-pledges-to-prevent-political-interference-in-rare-dis